A birth control pill for men? When?

When will men have their own birth control pill? Scientists have been predicting the debut of a male pill within 5 years for the last 30 years. The factors accounting for that delay—and new optimism that a male pill will emerge within a decade—are the topic of a story in the current edition of Chemical & Engineering News. C&EN is the weekly newsmagazine of the American Chemical Society, the world's largest scientific society.

In the story, Michael M. Torrice, C&EN associate editor, describes the need for a male version of the oral contraceptive pill that revolutionized family planning 50 years ago. For example, there are few choices of contraceptives for , half of all U.S. pregnancies are unintended, and those pregnancies cost state and federal programs about $11 billion annually.

Despite that need, the few pharmaceutical companies working to develop a male pill have discontinued research during the last five years. The story explains the scientific and regulatory hurdles in developing new contraceptives and describes promising new research on so-called non-hormonal male contraceptives.

More information: "Hunt for the Male Pill: Scientists Search for a Drug that Can Reversibly Derail Sperm Production": cen.acs.org/articles/90/i39/Hu… -Pill-Continues.html

add to favorites email to friend print save as pdf

Related Stories

Gradual bone reduction seen in some pill users

Jul 19, 2011

Birth control pills may reduce a woman's bone density, according to a study published online July 13 in The Journal of Clinical Endocrinology and Metabolism by Group Health Research Institute (GHRI) scientists. Impacts on bon ...

Recommended for you

Express Scripts turns to AbbVie in huge hepatitis C deal

33 minutes ago

The nation's largest pharmacy benefits manager is throwing its weight into a fight over the high cost of treating hepatitis C, saying it will cover a drug from AbbVie while pulling back on those from rival drugmakers.

FDA OKs Cubist antibiotic for serious infections

Dec 20, 2014

The Food and Drug Administration has approved a new medicine to fight complex infections in the abdomen and urinary tract, the fourth antibiotic the agency has approved since May.

Xtoro approved for swimmer's ear

Dec 18, 2014

(HealthDay)—Xtoro (finafloxacin otic suspension) eardrops have been approved by the U.S. Food and Drug Administration to treat swimmer's ear, clinically known as acute otitis externa.

Drug interaction identified for ondansetron, tramadol

Dec 18, 2014

(HealthDay)—In the early postoperative period, ondansetron is associated with increased requirements for tramadol consumption, according to a review and meta-analysis published online Dec. 10 in Anaesthesia.

New system targets germs in donated blood plasma

Dec 17, 2014

(HealthDay)—A new system designed to eliminate germs in donated blood plasma and reduce the risk of transmitting a plasma-borne infection has been approved by the U.S. Food and Drug Administration.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.